CI

At a glance

ClinicalIndex Comparison Record
N/AUnknown· 800 target
Drug / intervention
Histopathological review, long-term prognosis and quality of life follow-upother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05907824
NCT05907824N/AUnknown
CompareCT.gov

Long-term Prognosis Comparison Between Parenchyma-sparing and Oncologic Resections for Non-functional Neuroendocrine Tumors of the Pancreatic Body and Tail ≤ 3cm: a Real-world Data Study

Fudan University·observational·Posted Jun 18, 2023·Updated Sep 13, 2023

In Brief

An observational study evaluating Histopathological review, long-term prognosis and quality of life follow-up for Non Functioning Pancreatic Endocrine Tumor. Targeting 800 participants across 1 site.

Detailed Summary

This study aims to quantify the malignant potential of non-functional neuroendocrine tumors of the pancreatic body and tail ≤ 3 cm by collecting real-world data from large pancreatic centers across the country, and to evaluate the appropriateness of parenchyma-sparing resection and oncologic resection.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsNon Functioning Pancreatic Endocrine Tumor
CountriesChina
CollaboratorsThe Third Affiliated Hospital of Soochow University, Qilu Hospital of Shandong University, First Affiliated Hospital Xi'an Jiaotong University, Southern Medical University, China

Timeline

N/AUnknownOverdue
202420252026
First PostedJun 18, 2023
Enrollment StartMay 1, 2023
Primary CompletionDec 31, 2023
TodayJul 1, 2026
Enrollment to primary: 8 monthsPosted 3.0 years ago

Interventions

Histopathological review, long-term prognosis and quality of life follow-upother

Histopathological review, long-term prognosis and quality of life follow-up